New hope for debilitating pain? study tests repurposed drug
NCT ID NCT06306157
Summary
This study is exploring if a very low dose of an existing medication, naltrexone (called LDN), can help manage the severe pain and other symptoms of Complex Regional Pain Syndrome (CRPS). Over six months, 40 participants will take either LDN or a placebo (inactive pill) daily to see if it reduces their pain and improves their quality of life. The main goal is to see if this type of long-term medication study is practical to run and to gather early data on whether LDN might be a helpful new treatment option for this challenging condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital for Special Surgery
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.